Bolenz C - Search Results

1

Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.

Fernández MI, Bolenz C, Trojan L, Steidler A, Weiss C, Alken P, Grobholz R, Michel MS. Fernández MI, et al. Among authors: bolenz c. Eur Urol. 2008 Mar;53(3):571-8. doi: 10.1016/j.eururo.2007.08.030. Epub 2007 Aug 24. Eur Urol. 2008. PMID: 17804149

2

Intravesical mitomycin C for superficial transitional cell carcinoma.

Bolenz C, Cao Y, Arancibia MF, Trojan L, Alken P, Michel MS. Bolenz C, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1273-82. doi: 10.1586/14737140.6.8.1273. Expert Rev Anticancer Ther. 2006. PMID: 16925493 Review.

3

The modern management of upper tract urothelial cancer: surgical treatment.

Arancibia MF, Bolenz C, Michel MS, Keeley FX Jr, Alken P. Arancibia MF, et al. Among authors: bolenz c. BJU Int. 2007 May;99(5):978-81. doi: 10.1111/j.1464-410X.2007.06705.x. BJU Int. 2007. PMID: 17437429 Review. No abstract available.

4

[Complications and side effects of low dose rate brachytherapy for the treatment of prostate cancer: data on a 13 year follow-up study from Mannheim].

Trojan L, Harrer K, Schäfer J, Voss M, Welzel G, Bolenz C, Wenz F, Alken P, Michel MS. Trojan L, et al. Among authors: bolenz c. Urologe A. 2007 Nov;46(11):1542-7. doi: 10.1007/s00120-007-1369-7. Urologe A. 2007. PMID: 17622506 German.

5

Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo.

Bolenz C, Wenzel M, Cao Y, Trojan L, Häcker A, Arancibia MF, Alken P, Michel MS. Bolenz C, et al. J Endourol. 2007 Jul;21(7):789-94. doi: 10.1089/end.2006.0355. J Endourol. 2007. PMID: 17705773

6

Experimental models for therapeutic studies of transitional cell carcinoma.

Gabriel U, Bolenz C, Michel MS. Gabriel U, et al. Among authors: bolenz c. Anticancer Res. 2007 Sep-Oct;27(5A):3163-71. Anticancer Res. 2007. PMID: 17970057 Free article. Review.

7

Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.

Bolenz C, Becker A, Trojan L, Schaaf A, Cao Y, Weiss C, Alken P, Michel MS. Bolenz C, et al. Urol Oncol. 2007 Nov-Dec;25(6):476-82. doi: 10.1016/j.urolonc.2007.01.017. Urol Oncol. 2007. PMID: 18047955

8

Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology.

Wendt-Nordahl G, Sagi S, Bolenz C, Alken P, Michel MS, Knoll T. Wendt-Nordahl G, et al. Among authors: bolenz c. Urol Res. 2008 Feb;36(1):25-9. doi: 10.1007/s00240-007-0127-z. Epub 2007 Dec 7. Urol Res. 2008. PMID: 18074125

9

Hemostatic properties of four devices for partial nephrectomy: a comparative ex vivo study.

Honeck P, Wendt-Nordahl G, Bolenz C, Peters T, Weiss C, Alken P, Michel MS, Häcker A. Honeck P, et al. Among authors: bolenz c. J Endourol. 2008 May;22(5):1071-6. doi: 10.1089/end.2007.0236. J Endourol. 2008. PMID: 18429683

10

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.

Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C. Herrmann E, et al. Among authors: bolenz c. Int J Urol. 2008 Jul;15(7):607-11. doi: 10.1111/j.1442-2042.2008.02059.x. Epub 2008 May 2. Int J Urol. 2008. PMID: 18462352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters